Today’s guest post comes from Jenna Mitby-Manning, Senior Director of Commercial Strategy & Insights, Access & Adherence at RxCrossroads by McKesson.
Jenna explains how data-driven solutions accelerate time to therapy, improve patient outcomes, and allow biopharma companies to make informed strategic decisions.
Click here to learn more about RxCrossroads' therapy access and adherence solutions.
Read on for Jenna’s insights.
Read more »
Source: Post feed
